2023-01-202024-01-312024-01-31false14605868ELONGEYES INSTRUMENTS LTD2024-09-2346520iso4217:GBPxbrli:pure146058682023-01-20146058682024-01-31146058682023-01-202024-01-31146058682023-01-19146058682023-01-19146058682023-01-192023-01-1914605868bus:SmallEntities2023-01-202024-01-3114605868bus:AuditExempt-NoAccountantsReport2023-01-202024-01-3114605868bus:AbridgedAccounts2023-01-202024-01-3114605868bus:PrivateLimitedCompanyLtd2023-01-202024-01-3114605868core:WithinOneYear2024-01-3114605868core:AfterOneYear2024-01-3114605868core:WithinOneYear2023-01-1914605868core:AfterOneYear2023-01-1914605868core:ShareCapital2024-01-3114605868core:SharePremium2024-01-3114605868core:RevaluationReserve2024-01-3114605868core:OtherReservesSubtotal2024-01-3114605868core:RetainedEarningsAccumulatedLosses2024-01-3114605868core:ShareCapital2023-01-1914605868core:SharePremium2023-01-1914605868core:RevaluationReserve2023-01-1914605868core:OtherReservesSubtotal2023-01-1914605868core:RetainedEarningsAccumulatedLosses2023-01-1914605868core:LandBuildings2024-01-3114605868core:PlantMachinery2024-01-3114605868core:Vehicles2024-01-3114605868core:FurnitureFittings2024-01-3114605868core:OfficeEquipment2024-01-3114605868core:NetGoodwill2024-01-3114605868core:IntangibleAssetsOtherThanGoodwill2024-01-3114605868core:ListedExchangeTraded2024-01-3114605868core:UnlistedNon-exchangeTraded2024-01-3114605868core:LandBuildings2023-01-1914605868core:PlantMachinery2023-01-1914605868core:Vehicles2023-01-1914605868core:FurnitureFittings2023-01-1914605868core:OfficeEquipment2023-01-1914605868core:NetGoodwill2023-01-1914605868core:IntangibleAssetsOtherThanGoodwill2023-01-1914605868core:ListedExchangeTraded2023-01-1914605868core:UnlistedNon-exchangeTraded2023-01-1914605868core:LandBuildings2023-01-202024-01-3114605868core:PlantMachinery2023-01-202024-01-3114605868core:Vehicles2023-01-202024-01-3114605868core:FurnitureFittings2023-01-202024-01-3114605868core:OfficeEquipment2023-01-202024-01-3114605868core:NetGoodwill2023-01-202024-01-3114605868core:IntangibleAssetsOtherThanGoodwill2023-01-202024-01-3114605868core:ListedExchangeTraded2023-01-202024-01-3114605868core:UnlistedNon-exchangeTraded2023-01-202024-01-3114605868core:MoreThanFiveYears2023-01-202024-01-3114605868core:Non-currentFinancialInstruments2024-01-3114605868core:Non-currentFinancialInstruments2023-01-1914605868dpl:CostSales2023-01-202024-01-3114605868dpl:DistributionCosts2023-01-202024-01-3114605868core:LandBuildings2023-01-202024-01-3114605868core:PlantMachinery2023-01-202024-01-3114605868core:Vehicles2023-01-202024-01-3114605868core:FurnitureFittings2023-01-202024-01-3114605868core:OfficeEquipment2023-01-202024-01-3114605868dpl:AdministrativeExpenses2023-01-202024-01-3114605868core:NetGoodwill2023-01-202024-01-3114605868core:IntangibleAssetsOtherThanGoodwill2023-01-202024-01-3114605868dpl:GroupUndertakings2023-01-202024-01-3114605868dpl:ParticipatingInterests2023-01-202024-01-3114605868dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-202024-01-3114605868core:ListedExchangeTraded2023-01-202024-01-3114605868dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-202024-01-3114605868core:UnlistedNon-exchangeTraded2023-01-202024-01-3114605868dpl:CostSales2023-01-192023-01-1914605868dpl:DistributionCosts2023-01-192023-01-1914605868core:LandBuildings2023-01-192023-01-1914605868core:PlantMachinery2023-01-192023-01-1914605868core:Vehicles2023-01-192023-01-1914605868core:FurnitureFittings2023-01-192023-01-1914605868core:OfficeEquipment2023-01-192023-01-1914605868dpl:AdministrativeExpenses2023-01-192023-01-1914605868core:NetGoodwill2023-01-192023-01-1914605868core:IntangibleAssetsOtherThanGoodwill2023-01-192023-01-1914605868dpl:GroupUndertakings2023-01-192023-01-1914605868dpl:ParticipatingInterests2023-01-192023-01-1914605868dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-192023-01-1914605868core:ListedExchangeTraded2023-01-192023-01-1914605868dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-192023-01-1914605868core:UnlistedNon-exchangeTraded2023-01-192023-01-1914605868core:NetGoodwill2024-01-3114605868core:IntangibleAssetsOtherThanGoodwill2024-01-3114605868core:LandBuildings2024-01-3114605868core:PlantMachinery2024-01-3114605868core:Vehicles2024-01-3114605868core:FurnitureFittings2024-01-3114605868core:OfficeEquipment2024-01-3114605868core:AfterOneYear2024-01-3114605868core:WithinOneYear2024-01-3114605868core:ListedExchangeTraded2024-01-3114605868core:UnlistedNon-exchangeTraded2024-01-3114605868core:ShareCapital2024-01-3114605868core:SharePremium2024-01-3114605868core:RevaluationReserve2024-01-3114605868core:OtherReservesSubtotal2024-01-3114605868core:RetainedEarningsAccumulatedLosses2024-01-3114605868core:NetGoodwill2023-01-1914605868core:IntangibleAssetsOtherThanGoodwill2023-01-1914605868core:LandBuildings2023-01-1914605868core:PlantMachinery2023-01-1914605868core:Vehicles2023-01-1914605868core:FurnitureFittings2023-01-1914605868core:OfficeEquipment2023-01-1914605868core:AfterOneYear2023-01-1914605868core:WithinOneYear2023-01-1914605868core:ListedExchangeTraded2023-01-1914605868core:UnlistedNon-exchangeTraded2023-01-1914605868core:ShareCapital2023-01-1914605868core:SharePremium2023-01-1914605868core:RevaluationReserve2023-01-1914605868core:OtherReservesSubtotal2023-01-1914605868core:RetainedEarningsAccumulatedLosses2023-01-1914605868core:NetGoodwill2023-01-1914605868core:IntangibleAssetsOtherThanGoodwill2023-01-1914605868core:LandBuildings2023-01-1914605868core:PlantMachinery2023-01-1914605868core:Vehicles2023-01-1914605868core:FurnitureFittings2023-01-1914605868core:OfficeEquipment2023-01-1914605868core:AfterOneYear2023-01-1914605868core:WithinOneYear2023-01-1914605868core:ListedExchangeTraded2023-01-1914605868core:UnlistedNon-exchangeTraded2023-01-1914605868core:ShareCapital2023-01-1914605868core:SharePremium2023-01-1914605868core:RevaluationReserve2023-01-1914605868core:OtherReservesSubtotal2023-01-1914605868core:RetainedEarningsAccumulatedLosses2023-01-1914605868core:AfterOneYear2023-01-202024-01-3114605868core:WithinOneYear2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:CostValuation2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-202024-01-3114605868core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3114605868core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3114605868core:Non-currentFinancialInstrumentscore:CostValuation2023-01-1914605868core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-1914605868core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-1914605868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-1914605868core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-1914605868core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-1914605868core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-1914605868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-1914605868core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-1914605868bus:Director12023-01-202024-01-31

ELONGEYES INSTRUMENTS LTD

Registered Number
14605868
(England and Wales)

Unaudited Financial Statements for the Period ended
31 January 2024

ELONGEYES INSTRUMENTS LTD
Company Information
for the period from 20 January 2023 to 31 January 2024

Director

LI, Haolong

Registered Address

Office 3 4a Nelson Road
London
SE10 9JB

Registered Number

14605868 (England and Wales)
ELONGEYES INSTRUMENTS LTD
Balance Sheet as at
31 January 2024

Notes

2024

£

£

ASSETS
Current assets
Cash at bank and in hand22,748
22,748
22,748
22,748
CAPITAL, RESERVES AND LIABILITIES
Capital and reserves
Called up share capital100
Profit and loss account(155,854)
(155,754)
Liabilities
Creditors amounts falling due within one year3178,502
22,748
The financial statements were approved and authorised for issue by the Director on 23 September 2024, and are signed on its behalf by:
LI, Haolong
Director
Registered Company No. 14605868
ELONGEYES INSTRUMENTS LTD
Notes to the Financial Statements
for the period ended 31 January 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

2024
Average number of employees during the year0
3.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables1,134
Bank borrowings and overdrafts16,993
Taxation and social security989
Accrued liabilities and deferred income159,386
Total178,502
4.Share capital
100 Ordinary shares of £1 each